ScopusElsevier Scopus
Status
Active
Coverage
1978–2026
Source type
Journal
Open access
Yes
CiteScore
0.8
Best quartile
Q4 · 22nd pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 148 / 191 | 22nd | Q4 |
| Pharmacology | 278 / 328 | 15th | Q4 |
Bulletin of Pharmaceutical Sciences. Assiut
ISSN 1110-0052
Publisher: Assiut University
Scopus · Q4Open Access
Is Bulletin of Pharmaceutical Sciences. Assiut indexed in Scopus? Yes — actively indexed in Scopus, coverage 1978–2026, best quartile Q4, CiteScore 0.8.
Is Bulletin of Pharmaceutical Sciences. Assiut in Web of Science? No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Bulletin of Pharmaceutical Sciences. Assiut open access? Yes — it is an open-access journal, listed in DOAJ.
0.8
CiteScore 2025
Scopus
Q4
Best quartile
22nd percentile
2
Indexed in
major indexes
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
Not listed in Web of Science.
ABDCAustralian Business Deans Council 2025
Not listed in ABDC.
DOAJDirectory of Open Access Journals (live)
Checking DOAJ…
FT50Financial Times research list
Not listed in FT50.
UT DallasUTD top-100 business research
Not listed in UT Dallas.
ONOS · APC coveredOne Nation One Subscription (Govt of India)
Not in the ONOS APC-supported list.
Publishing in this journal is not centrally APC-funded under One Nation One Subscription.
Official sources & links
Related journals
- Cancer Nanotechnology
- Ceska a Slovenska Farmacie
- Chinese Journal of Clinical Pharmacology and Therapeutics
- Chinese Journal of Pharmaceutical Biotechnology
- Chinese Pharmaceutical Journal
- Chinese Traditional and Herbal Drugs
- Clinical Pharmacology in Drug Development
- Critical Reviews in Therapeutic Drug Carrier Systems
Explore this journal in the interactive dashboard →
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.